Chemotherapy vs. allogeneic transplantation as post molecular remission therapy in patients aged less than 60 years with Philadelphia-positive ALL

被引：8
|
作者：
Wang, Libing [1 ]
Du, Juan [2 ]
Huang, Aijie [1 ]
Tang, Gusheng [1 ]
Gong, Shenglan [1 ]
Cheng, Hui [1 ]
Zhang, Weiping [1 ]
Yang, Jianmin [1 ]
Wang, Jianmin [1 ]
Hu, Xiaoxia [1 ]
机构：
[1] Changhai Hosp, Inst Hematol, Dept Hematol, Shanghai 200433, Peoples R China
[2] Changzheng Hosp, Dept Hematol, Shanghai 200003, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2020年 / 55卷 / 01期
基金：
中国国家自然科学基金;
关键词：
ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; ADULT PATIENTS; IMATINIB; IMPACT; PLUS; MRD;
D O I：
10.1038/s41409-019-0514-4
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：245 / 248
页数：4
相关论文
共 50 条
  • [1] Chemotherapy vs. allogeneic transplantation as post molecular remission therapy in patients aged less than 60 years with Philadelphia-positive ALL
    Libing Wang
    Juan Du
    Aijie Huang
    Gusheng Tang
    Shenglan Gong
    Hui Cheng
    Weiping Zhang
    Jianmin Yang
    Jianmin Wang
    Xiaoxia Hu
    Bone Marrow Transplantation, 2020, 55 : 245 - 248
  • [2] Comparison of microtransplantation, chemotherapy and allogeneic transplantation in post-remission therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia
    Cai, Bo
    Sun, Qiyun
    Qiao, Jianhui
    Yu, Changlin
    Hu, Kaixun
    Liu, Tieqiang
    Li, Bingxia
    Huang, Yajing
    Wang, Yi
    Zuo, Hongli
    Dong, Zheng
    Lei, Yaqing
    Liu, Zhiqing
    Yao, Bo
    Li, Caixia
    Ai, Huisheng
    Guo, Mei
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (11): : 3852 - 3866
  • [3] Allogeneic stem cell transplantation for Philadelphia-positive acute lymphoblastic leukaemia in recent years: a retrospective EBMT analysis of patients transplanted in first remission
    Ottmann, O. G.
    Labopin, M.
    Ruutu, T.
    Socie, G.
    Bekassy, A.
    Rambaldi, A.
    Samey, B.
    Esteve, J.
    Rocha, V.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S48 - S48
  • [4] Imatinib Mesylate (Gleevec) in the Treatment of 2 Patients with Philadelphia-Positive ALL Relapsing after Allogeneic Stem Cell Transplantation
    Keiji Sugimoto
    Michiaki Mikoshiba
    Kazuteru Ohashi
    Hideki Akiyama
    Hisashi Sakamaki
    International Journal of Hematology, 2002, 75 : 440 - 442
  • [5] Imatinib mesylate (gleevec) in the treatment of 2 patients with Philadelphia-positive ALL relapsing after allogeneic stem cell transplantation
    Sugimoto, K
    Mikoshiba, M
    Ohashi, K
    Akiyama, H
    Sakamaki, H
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (04) : 440 - 442
  • [6] Post-Remission Treatment with Allogeneic Stem Cell Transplantation Improves Outcome in Patients Aged 60 Years and Older with Acute Myeloid Leukemia in First Remission
    Versluis, Jurjen
    Hazenberg, Carin L. E.
    van Putten, Wim
    Passweg, Jakob R.
    Maertens, Johan
    Biemond, Bart J.
    Schouten, Harry C.
    Pabst, Thomas
    Lowenberg, Bob
    Ossenkoppele, Gert J.
    Vellenga, Edo
    Cornelissen, Jan J.
    BLOOD, 2014, 124 (21)
  • [7] Do Adult Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph plus ALL) Patients Require Allogeneic Transplant in First Remission (CR1)?
    Khadadah, Fatima M.
    Andrews, Claire
    Atenafu, Eshetu G.
    Schuh, Andre C.
    Maze, Dawn
    Yee, Karen
    Jarallah, Osamah Jamal S.
    Minden, Mark D.
    Schimmer, Aaron D.
    Chan, Steven M.
    Gupta, Vikas
    Kim, Dennis Dong Hwan
    Sibai, Hassan
    BLOOD, 2022, 140 : 3169 - 3170
  • [8] Imatinib and Interferon-Alpha Maintenance Therapy for Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph plus ALL) Ineligible for Allogeneic Stem Cell Transplantation (SCT).
    Pfeifer, Heike
    Wassmann, Barbara
    Kaebisch, Andreas
    Luebbert, Michael
    Leimer, Lothar
    Giagounidis, Aristoteles
    Hoelzer, Dieter
    Ottmann, Oliver G.
    BLOOD, 2009, 114 (22) : 806 - 806
  • [9] Major molecular response prior to allogeneic hematopoietic stem cell transplantation predicts better outcome in adult Philadelphia-positive acute lymphoblastic leukemia in first remission
    W-Z Cai
    J-N Cen
    J Chen
    F Chen
    C-C Fu
    Y Han
    Z-M Jin
    X Ma
    M Miao
    H-Y Qiu
    X-W Tang
    S-L Xue
    A-N Sun
    S-N Chen
    D-P Wu
    Bone Marrow Transplantation, 2017, 52 : 470 - 472
  • [10] Major molecular response prior to allogeneic hematopoietic stem cell transplantation predicts better outcome in adult Philadelphia-positive acute lymphoblastic leukemia in first remission
    Cai, W-Z
    Cen, J-N
    Chen, J.
    Chen, F.
    Fu, C-C
    Han, Y.
    Jin, Z-M
    Ma, X.
    Miao, M.
    Qiu, H-Y
    Tang, X-W
    Xue, S-L
    Sun, A-N
    Chen, S-N
    Wu, D-P
    BONE MARROW TRANSPLANTATION, 2017, 52 (03) : 470 - 472
12345